Surgical treatment device
By using probes and impedance matching circuits in surgical treatment devices, the power supply frequency and impedance characteristics of piezoelectric elements are controlled, and the problems of long heating time and heat diffusion in the prior art are solved, and the rapidity of soft tissues such as blood vessels is achieved , safely heat up.
Patent Information
- Application Number
- CN202380030954.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-31
- Filing Date
- 2023-01-23
- Publication Date
- 2024-11-12
AI Technical Summary
When existing ultrasonic treatment devices heat soft tissues such as blood vessels, the heat rises for a long time and heat spreads to living tissues, resulting in damage and making it difficult to effectively use in endoscopic/laparoscopic surgery.
A surgical treatment device is designed, including a probe, a power supply circuit, a flexible tubular sheath and an impedance matching circuit. By controlling the power supply frequency and impedance characteristics of the piezoelectric element, the direct transmission of ultrasonic waves and self-heating is achieved, and the direct transmission of ultrasonic waves and self-heating is shortened. The heating time is limited and the heat diffusion is limited.
It achieves rapid heating of soft tissues such as blood vessels, shortens the heating time, and reduces the damage to living tissues by heat, improving the efficiency and safety of the surgery.
Smart Images

Figure CN118946320A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a surgical treatment device. Background Art
[0002] In the medical field, it is known that various treatments are performed on a subject using an ultrasonic treatment instrument that generates ultrasonic vibrations. Patent document 1 describes the following: an ultrasonic transducer is controlled at two frequencies including a resonant frequency, and each frequency generates ultrasonic waves or generates heat. Patent document 2 describes a surgical treatment device that supplies power at the resonant frequency (first frequency) of a rectangular piezoelectric body unit and / or the resonant frequency (second frequency) of the entire ultrasonic probe as a stacked structure to a piezoelectric element, and performs coagulation / incision treatment of living tissue through the generated ultrasonic vibrations and heat. Patent document 3 describes an ultrasonic surgical system that has a control circuit that controls the drive power output from an output circuit, so that the temperature of a specified part of the cartilage is heated by ultrasonic vibrations and the cartilage is cut to a temperature of 120°C or above within 2.2 seconds. The resonant frequency of the piezoelectric element unit or the piezoelectric element unit is used in the ultrasonic vibration.
[0003] Previous technical literature
[0004] Patent Literature
[0005] Patent Document 1: Japanese Patent Application No. 2013-528071
[0006] Patent Document 2: Japanese Patent Application Publication No. 2015-43879
[0007] Patent Document 3: International Publication No. 2017 / 038722 Summary of the invention
[0008] Technical issues to be solved by the invention
[0009] In the ultrasonic transducer described in the above-mentioned Patent Document 1, heating is performed so as not to damage the sample, and the heating time from room temperature to 95°C is within 2 minutes, the reaching temperature is low, and the time required for heating is long. In the surgical treatment device described in the above-mentioned Patent Document 2, there is no record of the temperature dependence of the actual size / dielectric constant (resonance frequency) of the piezoelectric element and the heating rate, and the actual heating time is also unclear. In the ultrasonic surgical system described in the above-mentioned Patent Document 3, cartilage is cut by the interaction of vibration and heat. The temperature of the cartilage is set to 45°C to 220°C, preferably to a specified temperature within the range of 120°C to 160°C. The heat generation rate of soft tissues such as blood vessels based on ultrasonic vibration is much lower than that of cartilage, and it is not easy to heat up soft tissues such as blood vessels in the same way as the cartilage.
[0010] The treatment instruments using existing ultrasonic waves convert part of the ultrasonic waves into frictional heat to heat up the vicinity of the treatment part such as a blood vessel, and the time required to heat up to the desired temperature is long. In addition, by using a rod-shaped transmission element for transmitting strong ultrasonic vibrations to the treatment part, the treatment instrument is large in size and has no flexibility, so it is difficult to use in endoscopic / laparoscopic surgery. In addition, when a method of heating the vicinity of the treatment part such as a blood vessel is used in combination, the time required to heat up to the desired temperature is long, and there is a risk that the heat is widely transmitted to living tissues other than the treatment part and causes damage. Therefore, it is required that in addition to ultrasonic vibrations, the sealed treatment part such as a blood vessel can also effectively generate self-heat and directly transmit it to the vicinity of the treatment part, thereby shortening the heating time to the desired temperature and minimizing the damage caused by the diffusion of heat into the living tissue near the treatment part.
[0011] The object of the present invention is to provide a surgical treatment device that can directly transmit ultrasound and self-heating to soft tissues such as blood vessels, shorten the time required for sealing, and minimize the damage caused by the diffusion of heat to living tissues near the soft tissues.
[0012] Means for solving technical problems
[0013] The surgical treatment device of the present invention comprises: a probe including a piezoelectric element; a power supply circuit for driving the piezoelectric element; a power supply wiring to the piezoelectric element; a flexible tubular sheath; a control mechanism for the amount of power supplied to the piezoelectric element; and an impedance matching circuit, wherein the probe has electrode layers for power supply on both sides of the piezoelectric element and has an opening and closing mechanism for grasping living tissue, the flexible tubular sheath includes the power supply wiring to the piezoelectric element and a part of the opening and closing mechanism of the probe, the driving frequency for power supply to the piezoelectric element is set to a frequency lower than the resonant frequency in the impedance characteristics of the probe, and the impedance matching circuit sets the driving frequency for power supply to the piezoelectric element to a frequency lower than the resonant frequency in the impedance characteristics of the treatment start temperature of the probe and to a frequency at which the reactance component of the impedance at the driving frequency becomes 0Ω.
[0014] Preferably, when the driving frequency of the probe is f, the resonance frequency is fr, and the anti-resonance frequency is fa, the range of the driving frequency in the impedance characteristic of the treatment start temperature of the probe alone satisfies the following formula (1).
[0015] 4fr-3fa≤f<fr (1)
[0016] More preferably, the range of the driving frequency in the impedance characteristic of the treatment start temperature of the probe unit satisfies the following formula (2).
[0017] 2.5fr-1.5fa≤f≤1.5fr-0.5fa (2)
[0018] Most preferably, the range of the driving frequency in the impedance characteristic at the treatment start temperature of the probe unit satisfies the following formula (3).
[0019] f=2fr-fa (3)
[0020] Preferably, the piezoelectric element has a rectangular planar shape and is polarized in the thickness direction.
[0021] Preferably, one surface of the piezoelectric element is fixed to the probe via a backing member, and the other surface of the piezoelectric element is covered with at least one or both of an acoustic matching layer and an insulating layer.
[0022] Preferably, the living tissue includes soft tissue of blood vessels.
[0023] Preferably, the driving frequency is a frequency lower than the resonance frequency, and the power consumption contributing to the generation of ultrasonic vibration at the driving frequency is within a range of at least 25% of the power consumption contributing to the generation of ultrasonic vibration at the resonance frequency.
[0024] Preferably, the resonant frequency in the impedance characteristics of the maximum reached temperature of the piezoelectric element of the probe is lower than the resonant frequency in the impedance characteristics of the treatment start temperature, and the difference between the resonant frequency in the impedance characteristics of the maximum reached temperature of the piezoelectric element and the resonant frequency in the impedance characteristics of the treatment start temperature is less than twice the difference between the resonant frequency and the anti-resonant frequency in the impedance characteristics of the treatment start temperature of the piezoelectric element.
[0025] Effects of the Invention
[0026] According to the present invention, ultrasonic waves and self-heating can be directly transmitted to soft tissues such as blood vessels, thereby shortening the time required for sealing and minimizing the damage caused by heat diffusion to living tissues near the soft tissues. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 It is an explanatory diagram for explaining the structure of an endoscope system (A) and the structure of a surgical treatment device (B).
[0028] Figure 2 This is an explanatory diagram showing a state where an ultrasonic treatment instrument is inserted into an endoscope.
[0029] Figure 3 The diagram is a perspective view of a state where the holding piece of the ultrasonic treatment instrument is closed (A) and opened (B).
[0030] Figure 4 These are cross-sectional views of a holding piece of an ultrasonic treatment instrument in a closed state (A) and an open state (B).
[0031] Figure 5 is along Figure 4 A cross-sectional view taken along line VI-VI of (A).
[0032] Figure 6 This is a block diagram showing an overview of a surgical treatment device.
[0033] Figure 7 It is the equivalent circuit diagram of the piezoelectric element.
[0034] Figure 8 It is an explanatory diagram of the impedance characteristics of the piezoelectric element according to the present embodiment.
[0035] Fig. 9 It is an explanatory diagram of the admittance characteristic of the piezoelectric element according to the present embodiment.
[0036] Fig.10 This is a diagram for explaining power consumption when an AC voltage of 10 V is applied to a piezoelectric element.
[0037] Fig.11 This is an impedance matching circuit diagram in which, among the power consumption of the probe of the present embodiment, the power consumption contributing to self-heating exceeds the power consumption contributing to the generation of ultrasonic vibration.
[0038] Fig.12 This is an explanatory diagram showing the change in reactance during impedance adjustment.
[0039] Fig.13 This is a diagram showing the details of the probe power consumption during impedance adjustment.
[0040] Fig.14 This is a diagram for explaining the resonant frequency, anti-resonant frequency, and driving frequency range of the probe at each temperature.
[0041] Fig.15 This is a diagram for explaining the temperature dependency of impedance characteristics.
[0042] Fig.16 This is a diagram for explaining the dependence of the total power consumption of the probe on the driving frequency.
[0043] Fig.17 These are diagrams to explain the probe impedance before and after adjustment.
[0044] Fig.18 This is a diagram illustrating the change in probe power consumption after impedance adjustment. DETAILED DESCRIPTION
[0045] Figure 1 The endoscope system 10 used in combination with the surgical treatment device 20 is shown. Figure 1 (A) and a surgical treatment device 20 having an ultrasonic treatment device 21 Figure 1(B) composition. Figure 1 As shown in (A), the endoscope system 10 includes an endoscope 12, a light source device 14, a processor device 15, a display 16, and a user interface (UI) 17. The endoscope 12 photographs the observation object. The light source device 14 emits illumination light to irradiate the observation object. The processor device 15 performs system control of the endoscope system 10. The display 16 is a display unit that displays an observation image based on the endoscopic image. The user interface (UI) 17 is an input device such as a mouse and a keyboard for inputting settings to the processor device 15, etc.
[0046] The endoscope 12 is optically connected to the light source device 14 and electrically connected to the processor device 15. The endoscope 12 has an insertion portion 12a inserted into the subject, an operating portion 12b provided at the base end portion of the insertion portion 12a, a bending portion 12c provided at the front end side of the insertion portion 12a, and a front end portion 12d. The bending portion 12c is bent by operating the angle button 12e of the operating portion 12b. As a result, the front end portion 12d faces the desired direction. In addition to the angle button 12e, a forceps opening 12f is provided on the operating portion 12b. The forceps opening 12f is an entrance for inserting an endoscopic treatment instrument such as an ultrasonic treatment instrument 21. The endoscopic treatment instrument is used in a state of being inserted into the forceps opening 12f.
[0047] Although not shown in the figure, an observation window and a lighting window are provided at the front end surface of the front end portion 12d. An image sensor (not shown) and the like are arranged on the inner side of the observation window, and an optical cable (not shown) is arranged on the inner side of the lighting window. The signal line of the image sensor and the optical cable are connected to the processor device 15 and the light source device 14, respectively.
[0048] The processor device 15 is electrically connected to the display 16 and the user interface 17. The processor device 15 performs image processing and the like on the endoscopic image captured by the image sensor and displays the image on the display 16.
[0049] like Figure 1 As shown in (B), the surgical treatment device 20 includes an ultrasonic treatment device 21, which is one of the endoscopic treatment devices inserted into the subject through the endoscope 12, and an ultrasonic driving device 22 that supplies power. The ultrasonic treatment device 21 includes a flexible tubular sheath 21a, an operating portion 21b, and a probe 30, and is electrically connected to the ultrasonic driving device 22. The flexible tubular sheath 21a is a tubular sheath formed of a flexible material such as a soft resin, and is inserted into the forceps channel 12g of the endoscope 12. The surgical treatment device 20 including the ultrasonic treatment device 21 is used, for example, for sealing and incision used in laparoscopic surgery. The probe 30 is located at the front end of the ultrasonic treatment device 21 and grasps living tissue. The grasped living tissue is soft tissue such as blood vessels.
[0050] like Figure 2 As shown, a forceps channel 12g for inserting the ultrasonic treatment instrument 21 is provided in the insertion portion 12a having the front end portion 12d. In the ultrasonic treatment instrument 21 inserted in the forceps channel opening 12f, the probe 30 protrudes from the forceps outlet 12h of the front end portion 12d. One end of the forceps channel 12g is connected to the forceps outlet 223, and the other end is connected to the forceps channel opening 12f provided in the operation portion 12b. In addition, the forceps channel 12g is also used as a path for conveying a cleaning liquid such as water from the forceps outlet 12h and a path for sucking body fluids such as blood, body metabolites and other contents. The ultrasonic drive device 22 supplies power to the ultrasonic treatment instrument 21.
[0051] like Figure 3 As shown, the probe 30 includes a pair of gripping pieces 31 that can be opened and closed in the vertical direction, an opening and closing mechanism 32 for opening and closing the gripping pieces 31, and a supporting member 33 that supports them. Furthermore, the flexible tubular sheath 21a includes a part of the supporting member 33. Figure 3 (A) shows a state where the holding piece 31 is closed. Figure 3 (B) shows the state where the holding piece 31 is opened. The holding pieces 31a and 31b are formed into semi-cylindrical shapes respectively, and the probe 30 in the closed state becomes a cylindrical shape, which is at least less than the circumference of the flexible tubular sheath 21a. Figure 3 As shown in FIG. 2(B) , acoustic matching layers 35 are provided on the inner surfaces of the pair of holding pieces 31 , which are opposite to each other. The opening and closing of the holding pieces 31 is the opening and closing of the probe 30 .
[0052] When the probe 30 is opened, the structure S such as a blood vessel is passed between the holding piece 31a and the holding piece 31b and the probe 30 is closed, so that the inner surfaces of the pair of holding pieces 31a and 31b are brought close to each other and the structure S such as a blood vessel as a soft tissue is held between the pair of holding pieces 31. In this way, the structure S such as a blood vessel to be treated by sealing is held by the holding piece 31. A large amount of water is contained in the blood vessel, which is a factor in delaying the temperature rise. Therefore, the water contained in the living tissue of the holding piece 31 is squeezed out by the appropriate holding (pressurization) of the structure S, and the denaturation / adhesion of the remaining living tissue is promoted, thereby improving the sealing effect. In addition, the appropriate holding pressure for obtaining the sealing effect in this treatment instrument is 10 to 50N.
[0053] Figure 4 is a cross-sectional view near the probe 30, Figure 4 (A) is a cross-sectional view showing a state where the probe 30 is closed, Figure 4(B) is a cross-sectional view showing the probe 30 in an open state. An operation wire 34 is inserted into the flexible tubular sheath 21a. The operation wire 34 transmits the user's opening and closing operation based on the operation part 21b of the ultrasonic treatment device 21 to the opening and closing mechanism 32. During the opening and closing operation, the operation wire 34 is pulled by the flexible tubular sheath 21a to become a closed state, and is pushed to the front end to open the opening and closing mechanism 32.
[0054] In the holding piece 31a and the holding piece 31b, an acoustic matching layer 35, an ultrasonic vibrator 36 and a backing member 37 are embedded on the inner surface of the clamping structure S. The ultrasonic vibration generated by the ultrasonic vibrator 36 is used to increase the temperature and seal the structure S such as the blood vessel. One surface of the ultrasonic vibrator 36 is fixed to the probe housing via the backing member 37, and the other surface is covered with an insulating layer and / or an acoustic matching layer 35. Figure 5 Along Figure 4 The cross-sectional view taken along line VI-VI of (A) is used for explanation.
[0055] like Figure 5 As shown in FIG. 1 , an acoustic matching layer 35 and an ultrasonic transducer 36 are stacked in parallel inside the holding pieces 31a and 31b of the probe 30. The backing member 37 is made of a rigid material such as hard rubber, and supports the ultrasonic transducer 36 from the back side (the side opposite to the acoustic matching layer 35), that is, the holding piece side. The backing member 37 is preferably in the shape of a semi-cylindrical arc along the holding pieces 31a and 31b. The ultrasonic transducer 36 is a structure in which an electrode layer 38a and an electrode layer 38b formed in a plate shape and thinner than the piezoelectric element 39 are stacked on both sides of the piezoelectric element 39 formed in a plate shape. The piezoelectric element 39 is composed of a rectangular plane shape and is polarized in the thickness direction. Therefore, the direction of the ultrasonic vibration generated by the ultrasonic transducer 36 is parallel to the holding direction Y held by the probe 30. In addition, the vibration direction Dk of the ultrasonic transducer 36 is parallel to the thickness direction Dx of the piezoelectric element 39.
[0056] The acoustic matching layer 35 is provided to achieve acoustic impedance matching between the patient's body and the ultrasonic transducer 36. The acoustic matching layer 35 is provided outside the ultrasonic transducer 36, and strictly speaking, overlaps the ultrasonic transducer 36 on the side facing the structure S held by the probe 30. The acoustic matching layer 35 can improve the transmittance of ultrasonic waves.
[0057] As the material of the acoustic matching layer 35, various organic materials having an acoustic impedance value closer to the acoustic impedance value of the human body than the piezoelectric element 39 can be used. Specifically, epoxy resin, silicone rubber, polyimide, polyethylene, etc. can be mentioned. The acoustic matching layer 35 is formed of multiple layers, and the material and the number of layers are appropriately selected according to the required acoustic impedance value.
[0058] An air gap layer 40, which is a gap that enables ultrasonic waves to be reflected by the air inside, is formed between the electrode layer 38b on the outer surface side of the plate-shaped ultrasonic vibrator 36 and the arc-shaped backing member 37. The air gap layer 40 has a function of reflecting ultrasonic waves emitted from the back side of the ultrasonic vibrator 36, and can effectively transmit ultrasonic vibrations to a structure S such as a blood vessel. In addition, a material that reflects ultrasonic waves may be filled instead of the air gap layer 40.
[0059] The piezoelectric element 39 preferably has a mechanical quality factor Qm of 500 or more. The mechanical quality factor Qm is a factor indicating elastic loss due to vibration and is expressed as the inverse of the mechanical loss factor. When the piezoelectric element 39 elastically vibrates, loss is generated inside and converted into heat.
[0060] When the temperature rise due to the heat generated by the piezoelectric element 39 exceeds 100°C, the possibility of depolarization of the piezoelectric element 39 must also be considered. The Curie temperature of the piezoelectric element 39 is about 1.5 times, preferably more than 2 times, the target arrival temperature of the piezoelectric element surface when power is supplied. For example, when the target arrival temperature of the piezoelectric element surface is set to 200°C, the Curie temperature of the piezoelectric element 39 used is set to a value of 300°C or more, preferably 400°C or more. In addition, if the protein exceeds 200°C, there is a possibility of carbonization, so the target arrival temperature is preferably set to a maximum of 200°C.
[0061] The probe 30 including the piezoelectric element 39 is preferably set to a size that can be used for endoscopic surgery or laparoscopic surgery, and the thickness of the piezoelectric element 39 alone is preferably in the range of 0.2 mm to 1 mm, 2 mm to 4 mm in width, and 10 mm to 30 mm in length, which can also be accommodated in the probe 30. In addition, it is also allowed to divide the width and length of the piezoelectric element 39 into two. For example, two parts with a width of 1 mm are arranged so that the overall width is 2 mm. If the thickness of the piezoelectric element 39 is thick, the heat generated by the side that does not contact the living tissue is not easily transmitted to the living tissue relative to the side that contacts the living tissue of the piezoelectric element 39, and the temperature difference between the two sides may become larger. On the other hand, if the thickness of the piezoelectric element 39 is thin, the heat generated by the piezoelectric element as a whole is reduced. In addition, the resonant frequency and anti-resonant frequency of the piezoelectric element 39 in the state of being accommodated in the probe 30 depend on the thickness of the piezoelectric element. The thinner the piezoelectric element 39, the higher the frequency may be.
[0062] Furthermore, in the piezoelectric element 39, a member holding one side of the piezoelectric element 39 is held by the probe housing via a backing member 37 having low thermal conductivity, and a surface on the side in contact with the living tissue is covered by an acoustic matching layer 35 made of a member having high thermal conductivity or a surface protection layer having high thermal conductivity. Here, it is also effective to provide an air gap layer in a portion between the ultrasonic vibrator 36 and the backing member 37 to more effectively reduce the heat conductivity.
[0063] Furthermore, the difference in thermal expansion coefficients between the piezoelectric element 39 and the acoustic matching layer 35 generates internal stress between the ultrasonic transducer 36 and the acoustic matching layer 35 when the temperature rises, which becomes a factor of variation in the temperature dependence of the resonant frequency fr and the antiresonant frequency fa of the piezoelectric element described later. Therefore, the acoustic matching layer 35 is selected in consideration of the thermal expansion coefficient of the piezoelectric element 39.
[0064] Even when the reaching temperature of the piezoelectric element is high, it is preferable that the temperature change of the resonant frequency and the anti-resonant frequency of the probe is small. Specifically, as a condition for selecting the thermal expansion coefficient of the acoustic matching layer 35, the resonant frequency frs at the treatment start temperature, the resonant frequency fre at the maximum reaching temperature, and the anti-resonant frequency fas at the treatment start temperature preferably satisfy the following two equations (4) and (5).
[0065] The resonance frequency fre of the maximum reachable temperature is ≤ the resonance frequency frs of the treatment start temperature (4)
[0066] (resonance frequency frs at treatment start temperature - resonance frequency fre at maximum reached temperature) ≤ (anti-resonance frequency fas at treatment start temperature - resonant frequency frs at treatment start temperature) × 2 (5)
[0067] The electrode layers 38a and 38b are connected to the ultrasonic drive device 22 via a signal cable (not shown) constituting a power supply circuit. The signal cable has a flexible tubular sheath 21a. For example, wiring is performed along the inner circumference or outer circumference of the flexible tubular sheath 21a. When the ultrasonic treatment device 21 is connected to the ultrasonic drive device 22, the electrode layers 38a and 38b are electrically connected to the ultrasonic drive device 22 via the signal cable. In addition, one of the electrode layers 38a and 38b is connected to a ground wire via a signal cable or the like, and the other is supplied with power of an AC voltage signal described later from the ultrasonic drive device 22.
[0068] like Figure 6As shown, the ultrasonic driving device 22 constituting the surgical treatment device 20 includes a control mechanism 41, a signal transmitter 42, an amplifier 43, an impedance matching circuit 44, and a frequency monitor 47. The impedance matching circuit 44 is connected to the ultrasonic vibrator 36 including the piezoelectric element 39 of the probe 30 in the ultrasonic treatment instrument 21. The control mechanism 41 controls the amount of power supplied to the piezoelectric element 39, and the path connecting the signal transmitter 42, the amplifier 43, the impedance matching circuit 44, and the ultrasonic vibrator 36 includes a power supply circuit for driving the piezoelectric element.
[0069] In the ultrasonic driving device 22, programs related to various processes are stored in a program memory (not shown). The control unit 41 composed of a processor executes the program in the program memory to control the functions of the signal transmitter 42, amplifier 43 and impedance matching circuit 44.
[0070] The frequency used when driving the ultrasonic vibrator 36 is displayed on the frequency monitor 47. The signal transmitter 42 has a function of generating an AC voltage signal having an arbitrary frequency and waveform, and has, for example, the same structure and function as a well-known function generator. In addition, it is preferable to provide a current probe (not shown) and a current value monitor (not shown) composed of an oscilloscope or the like on the ultrasonic drive device 22.
[0071] The signal transmitter 42 outputs an AC voltage signal of a predetermined frequency. The predetermined frequency refers to the frequency at which the ultrasonic vibration of the piezoelectric element 39 reaches the maximum, that is, the resonance frequency fr. The piezoelectric element 39 has a resonance frequency corresponding to the thickness dimension. Specifically, when the thickness dimension is set to D1 (m), the resonance frequency corresponding to the thickness dimension D1 is set to fr (MHz), and the sound velocity of the piezoelectric (the speed of the sound wave propagating in the piezoelectric element 39) is set to v (m / sec), the relationship D1=v / 2fr is achieved.
[0072] The signal transmitter 42 outputs an AC voltage signal of a driving frequency f, such as the resonant frequency fr, to the amplifier 43. The amplifier 43 amplifies the AC voltage signal output from the signal transmitter 42 to a voltage level capable of driving the ultrasonic vibrator 36. The impedance matching circuit 44 is connected in series with the amplifier 43, and is capable of matching the input impedance of the AC voltage signal output from the amplifier 43 with the impedance of the ultrasonic vibrator 36.
[0073] The current probe measures the current value input to the ultrasonic vibrator 36 from the impedance matching circuit 44 and inputs it to the control mechanism 41. And, it is displayed on the current value monitor. The control mechanism 41 controls the signal transmitter 42 in such a way that the ultrasonic vibrator 36 is driven by the current value measured by the current probe. The control mechanism 41 controls the signal transmitter 42 so that the AC voltage signal for driving the ultrasonic vibrator 36 is continuously supplied. The continuous supply mentioned here means that the AC voltage signal is continuously output from the signal transmitter 42 without interruption at least in the driving of the ultrasonic vibrator 36. By driving the ultrasonic vibrator 36, treatment based on the ultrasonic treatment device 21 can be performed.
[0074] The present invention achieves this by adjusting impedance so that the power consumption contributing to self-heating of the piezoelectric element 39 is greater than the power consumption contributing to ultrasonic vibration. That is, the surgical treatment device 20 having the impedance matching circuit 44 taking the self-heating of the piezoelectric element 39 into consideration is used.
[0075] according to Figure 7 to Figure 10 The impedance matching circuit 44 with impedance adjustment is realized by the results obtained in the embodiment shown, that is, the piezoelectric element 39 is made of C-213 (manufactured by FUJI CERAMICS CORPORATION) with a thickness of 0.5 mm, a length of 3 mm, and a width of 18 mm, and a temperature increase experiment for measuring and adjusting the impedance characteristics at 25°C is described as an embodiment.
[0076] Regarding the resonant frequency fr and the antiresonant frequency fa in the piezoelectric element 39 (the probe 30 having the piezoelectric element 39 ), the frequency at which the resistance component becomes maximum (the reactance component becomes zero) is the antiresonant frequency fa, and the frequency at which the admittance becomes maximum is the resonant frequency fr.
[0077] Figure 7 This is an equivalent circuit of the piezoelectric element 39, and the value of each element can be estimated by measuring the impedance characteristics and admittance characteristics. By using this equivalent circuit, the power consumption contributing to the ultrasonic vibration of the piezoelectric element 39 can be estimated from the resistor R0, and the power consumption contributing to self-heating can be estimated from the resistor Rs.
[0078] Figure 8 This is the ratio of voltage to current in the piezoelectric element 39 of this embodiment before impedance adjustment, that is, the impedance characteristic. A curve 50 represents the resistance component of the impedance characteristic, and a curve 51 represents the reactance component of the impedance characteristic.
[0079] Fig. 9 Curve 52 is in Figure 8 The admittance characteristic when measured under the same conditions is the inverse of the impedance characteristic, which expresses the ratio of current to voltage. Figure 8 and Fig. 9The impedance characteristics and reactance characteristics of the piezoelectric element 38 before impedance adjustment are 4.2 MHz and 4.5 MHz, respectively. Usually, the driving frequency f is generally set to the resonance frequency fr at which the ultrasonic vibration of the ultrasonic vibrator 36 becomes maximum.
[0080] Fig.10 is Figure 7 The power consumption when an AC voltage of 10V is applied to the equivalent circuit of . The power consumption curve 53 represents the total power consumption corresponding to the frequency, the power consumption curve 54 represents the power consumption that contributes to the generation of ultrasonic vibrations, and the power consumption curve 55 represents the power consumption that contributes to self-heating. The piezoelectric element 39 is driven at the frequency at which the ultrasonic vibration becomes the maximum, that is, the resonant frequency fr, and the power consumption that contributes to ultrasonic vibrations is greater than the power consumption that contributes to self-heating. In addition, in order to further reduce self-heating, the resonant frequency fr is sometimes set to a position slightly close to the anti-resonant frequency fa, and the proportion of power consumption that contributes to the generation of ultrasonic vibrations in the total power consumption is increased. The power consumption that contributes to the self-heating of the probe 30 is the difference between the total power consumption and the power consumption that contributes to the generation of ultrasonic vibrations.
[0081] On the other hand, in the present embodiment, the ratio of the power consumption contributing to the self-heating in the total power consumption of the piezoelectric element 39 is increased, and based on the above measurement results, an impedance matching circuit 44 is constructed in which the reactance component of the impedance is set to 0 Ω at the driving frequency f at which the power consumption contributing to the generation of ultrasonic vibration and the power consumption contributing to the self-heating become a desired ratio. In addition, if the driving frequency f becomes too low, ultrasonic vibration is hardly generated. Therefore, the power consumption contributing to the generation of ultrasonic vibration at the driving frequency f is determined within a range where the power consumption contributing to the generation of ultrasonic vibration at the resonant frequency fr is at least 25% or more.
[0082] like Fig.11 As shown, based on the above measurement results, a circuit that has been adjusted in impedance in consideration of self-heating is constructed. Specifically, it has an inductor L, a capacitor C, a power supply AC, and a piezoelectric element 39. The impedance of the equivalent circuit is adjusted, and the heating time of the living tissue is shortened. If the heating time is long, the heat transferred to the treatment part diffuses in the living tissue, and the temperature rises to the living part near the treatment, which is thermally damaged. Therefore, in order to minimize the heat diffusion in the living tissue, the shorter the heating time, the more advantageous it is.
[0083] In the electrical characteristics of the probe 30 having the accompanying structures such as the acoustic matching layer 35 of the probe shell with impedance adjustment and the state of holding a structure S such as a blood vessel, the frequency at which the absolute value of the ratio of current to voltage in the AC circuit, i.e., the admittance becomes maximum is substituted as the resonant frequency fr, and the frequency at which the absolute value of the admittance becomes minimum is substituted as the anti-resonant frequency fa.
[0084] Generally, the ultrasonic vibration efficiency of the probe at the resonance frequency fr is optimized by setting the reactance component of the impedance characteristic of the probe 30 at the resonance frequency fr to 0 Ω. On the other hand, the inventors found that heat energy is as important as ultrasonic energy in the probe performance required for sealing / cutting. Therefore, it is desired that the probe 30 is driven under the condition that the output of heat energy, i.e., the self-heating of the piezoelectric element 39, is considered in addition to the ultrasonic energy, and a driving method for the probe 30 is found.
[0085] Fig.12 Indicates accompanying Fig.11 The reactance changes of the impedance adjustment achieved. Regarding the capacitor C, it is adjusted in the range of 0.4nF to 1.2nF, and the inductor L is 4μH. Curve 59 shows the reactance of the capacitor C corresponding to the driving frequency f at 1.2nF, and curve 60 shows the reactance of the capacitor C corresponding to the driving frequency f at 0.4nF. As the reactance component increases, the optimal driving frequency f becomes lower, and the total power consumption tends to increase, but the ultrasonic vibration decreases. The optimal driving frequency f is the frequency at which the reactance component on the low frequency side becomes 0 Ω compared to the frequency at which the reactance component becomes the maximum value.
[0086] Fig.13 The details of the probe power consumption accompanying the impedance adjustment are shown. The power consumption that contributes to the self-heating of the probe is equivalent to the difference between the total power consumption and the power consumption that contributes to the generation of ultrasonic vibration. The power consumption curve group 62 represented by the dotted line is the total power consumption under the value of each capacitor C, and the power consumption curve group 63 represented by the solid line is the power consumption related to ultrasonic vibration under the value of each capacitor C. Therefore, it is expected that the optimal driving frequency f that takes into account the ratio of self-heating and ultrasonic vibration is selected on the basis of ensuring the total power consumption of the probe, and the impedance is adjusted. As a result, the heating time of the piezoelectric element 39 is shortened. The lower the value of the optimal driving frequency f becomes, the greater the total power consumption of the probe 30 having the piezoelectric element 39, and the less the power consumption that contributes to the generation of ultrasonic vibration.
[0087] The temperature dependence of the resonance frequency fr and the anti-resonance frequency fa of the probe 30 may be increased due to interference of the incidental environment of the piezoelectric element, that is, the backing member 37 or the acoustic matching layer 35. In this case, the drive frequency f is set in consideration of the target temperature zone. Specifically, when the resonance frequency fr of the probe 30 varies within the range from the treatment start temperature to the target temperature, the drive frequency f can be set to a drive frequency f that satisfies the allowable range of the resonance frequency fr and the drive frequency f in each temperature zone between the treatment start temperature and the target temperature.
[0088] The present invention mainly optimizes the driving conditions for actively promoting the self-heating of the piezoelectric element 39, and drives the piezoelectric element 39 at a frequency lower than the resonance frequency fr of the piezoelectric element 39 in the state of being accommodated in the probe 30, taking a state in which at least ultrasonic vibration is generated as a condition, and therefore an impedance matching circuit for this is added to the surgical treatment device 20. In addition, the actual driving frequency f does not have to be strict.
[0089] like Fig.14 As shown, the resonant frequency fr at 30°C is 4.2MHz, the anti-resonant frequency fa is 4.5MHz, and the range of the driving frequency f is greater than 3.3MHz and less than 4.2MHz. The resonant frequency fr at 100°C is 4.1MHz, the anti-resonant frequency fa is 4.4MHz, and the range of the driving frequency f is greater than 3.2MHz and less than 4.1MHz. The resonant frequency fr at 200°C is 3.9MHz, the anti-resonant frequency fa is 4.3MHz, and the range of the driving frequency f is greater than 2.7MHz and less than 3.9MHz. If a driving frequency f that is common to the temperature ranges of 30°C, 100°C and 200°C is selected, the range of the driving frequency f is greater than 3.3MHz and less than 3.9MHz. The calculation method of the range of the driving frequency at each temperature will be described later.
[0090] Fig.15 In the figure, the temperature dependence of the probe impedance characteristic is shown in the range of the treatment start temperature of 30°C and the maximum reachable temperature of 200°C. The 30°C curve 65 represents the resistance at 30°C, and the 30°C curve 66 represents the reactance at 30°C. The 100°C curve 67 represents the resistance at 100°C, and the 100°C curve 68 represents the reactance at 100°C. The 200°C curve 69 represents the resistance at 200°C, and the 200°C curve 70 represents the reactance at 200°C. In addition, the resonant frequency fr and the anti-resonant frequency fa at this time are as shown in FIG. Fig.14 The 30°C curve 66, the 100°C curve 68, and the 100°C curve 70 all have frequencies where the reactance component becomes 0Ω, and the range of the optimal driving frequency f at each temperature is lower than the values of these frequencies.
[0091] like Fig.16 As shown in FIG. 7 , the driving frequency f at which the total power consumption becomes the maximum is different for each temperature zone. As shown in the 30°C power consumption curve 72, the total power consumption becomes the maximum around 3.8 MHz around 30°C, as shown in the 100°C power consumption curve 73, the total power consumption becomes the maximum around 3.7 MHz around 100°C, and as shown in the 200°C power consumption curve 74, the total power consumption becomes the maximum around 3.6 MHz around 200°C. The higher the reaching temperature of the piezoelectric element 39 of the probe 30, the lower the value of the optimal driving frequency.
[0092] The control of the heat generation of the piezoelectric element 39 is implemented by adjusting the voltage or current by the power supply circuit. In addition, the driving frequency f during temperature rise is usually fixed, but when the temperature dependence of the resonance frequency fr of the probe 30 is large, a function of gradually changing the driving frequency f to the optimal probe temperature based on the probe temperature data obtained by the temperature measuring device (not shown) of the probe 30 can be provided.
[0093] In the present invention, living tissue is grasped by a probe 30 including a piezoelectric element 39, and the self-heating of the piezoelectric element 39 is transmitted to the living tissue together with the start of the prescribed power supply, and the resulting ultrasonic vibration is applied, thereby effectively sealing the living tissue through the synergistic effect of heat, vibration and grasping pressure.
[0094] The impedance matching circuit 44 is provided such that the driving frequency f of the probe 30 is lower than the resonant frequency fr of the probe 30 and the reactance component of the impedance of the probe 30 becomes 0Ω at the driving frequency f. The driving frequency f of the probe is set in a range for effective temperature increase by the resonant frequency fr of the probe and the anti-resonant frequency fa of the probe.
[0095] Fig.17 The impedance measurement and impedance adjustment results are shown when the piezoelectric element 39 contained in the probe 30 is C-213 with a thickness of 0.5 mm. In the impedance adjustment, the driving frequency f is shifted to the low-frequency side. Curve 76 is the resistance curve of the impedance characteristic. Curve 77 is the reactance curve of the impedance characteristic, and the driving frequency f becomes 4.2 MHz. Adjustment curve 78 is the adjustment curve when the driving frequency f is adjusted to 3.9 MHz, and adjustment curve 79 is the adjustment curve when the driving frequency f is adjusted to 3.6 MHz. The frequency at which the low-frequency side of curve 77 becomes 0Ω is the resonance frequency fr, and the frequency on the high-frequency side is the anti-resonance frequency fa. Among the frequencies at which the reactance components of the adjustment curves 78 and 79 become 0Ω, the low-frequency side is the driving frequency f, and the high-frequency side is about 4.5 MHz, that is, the anti-resonance frequency fa.
[0096] The self-heat of the piezoelectric element 39 in the probe 30 increases as the drive frequency f shifts to the low-frequency side, and the heat transfer to the living tissue, that is, the heating rate of the living tissue, increases, thereby shortening the treatment time until sealing. In addition, the power consumption of the probe depends on the applied voltage, and the desired heating rate and target temperature are maintained by adjusting the AC voltage.
[0097] like Fig.18As shown in the figure, within the measurement frequency range, the lower the adjusted driving frequency f is on the frequency side, the more the power consumption of the probe 30 increases. In the probe power consumption when a voltage of 10V is applied, the power consumption of the power consumption curve 90 when the driving frequency f is adjusted to 3.9MHz is greater than the power consumption curve 91 when the driving frequency f is adjusted to 4.2MHz, and the power consumption of the power consumption curve 89 when the driving frequency f is adjusted to 3.6MHz is further increased. That is, through adjustment, the lower the value of the optimal driving frequency f is, the greater the total power consumption of the probe 30.
[0098] According to the above, regarding the range of the driving frequency f in the impedance characteristics of the probe 30 alone, the relationship between the driving frequency f, the resonance frequency fr, and the anti-resonance frequency fa of the probe preferably satisfies the following formula (6). The driving frequency f is a value lower than the resonance frequency fr. In addition, if the driving frequency f is set to a frequency lower than the above range, the ultrasonic vibration of the probe 30 is almost not obtained. The value used to calculate the range of the driving frequency f is Fig.14 The values shown.
[0099] 4fr-3fa≤f<fr (6)
[0100] As the most ideal range of the driving frequency f of the probe 30, it is preferable that the following formula (7) is satisfied more than the formula (6).
[0101] 2.5fr-1.5fa≤f≤1.5fr-0.5fa (7)
[0102] As the most ideal driving frequency f of the probe 30, it is preferable to satisfy the following equation (8) which is the center of the range of equation (7).
[0103] f=2fr-fa (8)
[0104] In the present embodiment, both of the pair of holding pieces 31a and 31b constituting the probe 30 are provided with the ultrasonic vibrator 36, but the present invention is not limited thereto, and the ultrasonic vibrator 36 may be provided on only one of the pair of holding pieces 31a and 31b. In this case, the ultrasonic vibrator 36 is arranged parallel to the inner surface of one holding piece 31, and the inner surface of the other holding piece 31 facing the ultrasonic vibrator 36 is preferably formed of a material that reflects the ultrasonic vibration generated by the ultrasonic vibrator 36.
[0105] In the present embodiment, the hardware structure of the processing unit (processing unit) that executes various processes such as the control mechanism 41 is various processors (processors) as shown below. Various processors include general-purpose processors that execute software (programs) and function as various processing units, namely CPU (Central Processing Unit), GPU (Graphical Processing Unit), FPGA (Field Programmable Gate Array) and other processors that can change the circuit structure after manufacturing, namely Programmable Logic Device (PLD), and processors with circuit structures specially designed for executing various processes, namely dedicated circuits, etc.
[0106] One processing unit may be composed of one of these various processors, or may be composed of a combination of two or more processors of the same type or different types (for example, a combination of multiple FPGAs, a combination of a CPU and an FPGA, or a combination of a CPU and a GPU, etc.). Furthermore, multiple processing units may be composed of one processor. As an example of configuring multiple processing units with one processor, first, there is a method in which a processor is configured by a combination of one or more CPUs and software, such as represented by a computer such as a client or a server, and the processor functions as multiple processing units. Second, there is a method in which a processor is used to implement the functions of the entire system including multiple processing units by one IC (Integrated Circuit) chip, such as represented by a system on chip (System On Chip: SoC). In this way, various processing units are configured as a hardware structure using one or more of the above-mentioned various processors.
[0107] More specifically, the hardware structure of these various processors is an electric circuit in which circuit elements such as semiconductor elements are combined, and the hardware structure of the storage unit is a storage device such as a HDD (hard disc drive) or an SSD (solid state drive).
[0108] Furthermore, in the above-mentioned embodiment, the endoscope 12 combined with the ultrasonic treatment instrument 21 of the present invention is not specifically described, but any endoscope 12 may be used as long as it has a forceps channel for inserting the treatment instrument, for example, it may be a bronchoscope, an upper gastrointestinal endoscope, or a lower gastrointestinal endoscope, etc. The surgical treatment device 20 having the impedance matching circuit 44 of this embodiment is preferably implemented during manufacturing in a factory or the like.
[0109] Explanation of symbols
[0110] 10-endoscopic system, 12-endoscope, 12a-insertion portion, 12b-operation portion, 12c-bending portion, 12d-front end portion, 12e-angle knob, 12f-forceps channel opening, 12g-forceps channel, 12h-forceps outlet, 14-light source device, 15-processor device, 16-display, 17-user interface, 20-surgical treatment device, 21-ultrasonic treatment instrument, 21a-flexible tubular sheath, 21b-operation portion, 22-ultrasonic drive device , 30-probe, 31-holding piece, 31a-holding piece, 31b-holding piece, 32-opening and closing mechanism, 33-supporting member, 34-operating wire, 35-acoustic matching layer, 36-ultrasonic vibrator, 37-backing member, 38a-electrode, 38b-electrode, 39-piezoelectric element, 40-air gap layer, 41-control mechanism, 42-signal transmitter, 43-amplifier, 44-impedance matching circuit, 47-frequency monitor, 50-curve, 51-curve, 52 - curve, 53-power consumption curve, 54-power consumption curve, 55-power consumption curve, 59-curve, 60-curve, 62-power consumption curve group, 63-power consumption curve group, 65-30℃ curve, 66-30℃ curve, 67-100℃ curve, 68-100℃ curve, 69-200℃ curve, 70-200℃ curve, 72-30℃ power consumption curve, 73-100℃ power consumption curve, 74-200℃ power consumption curve, 76-curve, 77-curve, 78-adjustment curve, 79-adjustment curve, 89-power consumption curve, 90-power consumption curve, 91-power consumption curve, AC-power supply, C-capacitor, C0-capacitor, C1-capacitor, Cs-capacitor, Dx-thickness direction, fa-anti-resonance frequency, f-driving frequency, fr-resonance frequency, IL-current, L-inductor, L0-inductor, Ls-inductor, R0-resistance, Rs-resistance, S-structure, Y-holding direction.
Claims
1. A surgical treatment device comprising: a probe including a piezoelectric element; a power supply circuit for driving the piezoelectric element; a power supply wiring to the piezoelectric element; a flexible tubular sheath; a control mechanism for the amount of power supplied to the piezoelectric element; and an impedance matching circuit, The probe has electrode layers for power supply on both sides of the piezoelectric element and an opening and closing mechanism for grasping living tissue. The flexible tubular sheath includes a power supply wiring to the piezoelectric element and a part of the opening and closing mechanism of the probe. The impedance matching circuit sets a driving frequency for supplying power to the piezoelectric element to a frequency lower than a resonance frequency in the impedance characteristics at a treatment start temperature of the probe and a frequency at which a reactance component of impedance at the driving frequency becomes 0Ω.
2. The surgical treatment device according to claim 1, wherein: When the driving frequency of the probe is f, the resonance frequency is fr, and the anti-resonance frequency is fa, the range of the driving frequency in the impedance characteristic of the treatment start temperature of the probe unit satisfies the following formula (1), 4fr-3fa≤f <fr(1)。 3. The surgical treatment device according to claim 1, wherein: The driving frequency range in the impedance characteristic of the treatment start temperature of the probe unit satisfies the following formula (2): 2.5fr-1.5fa≤f≤1.5fr-0.5fa(2).
4. The surgical treatment device according to claim 1, wherein: The range of the driving frequency in the impedance characteristic of the treatment start temperature of the probe unit satisfies the following formula (3): f = 2fr-fa (3).
5. The surgical treatment device according to claim 1, wherein: The piezoelectric element is constituted by a rectangular planar shape, and is polarized in the thickness direction.
6. The surgical treatment device according to claim 1, wherein: One side of the piezoelectric element is fixed to the probe via a backing member. The other surface of the piezoelectric element is covered with at least one or both of an acoustic matching layer and an insulating layer.
7. The surgical treatment device according to claim 1, wherein: The living tissue is soft tissue including blood vessels.
8. The surgical treatment device according to claim 1, wherein: The driving frequency is a frequency lower than the resonance frequency, and a frequency in a range where power consumption contributing to generation of ultrasonic vibration at the driving frequency is at least 25% of power consumption contributing to generation of ultrasonic vibration at the resonance frequency.
9. The surgical treatment device according to any one of claims 1 to 8, wherein: The resonant frequency in the impedance characteristics of the maximum temperature reached by the piezoelectric element of the probe is lower than the resonant frequency in the impedance characteristics at the treatment start temperature, and the difference between the resonant frequency in the impedance characteristics of the maximum temperature reached by the piezoelectric element and the resonant frequency in the impedance characteristics at the treatment start temperature is less than twice the difference between the resonant frequency and the anti-resonant frequency in the impedance characteristics at the treatment start temperature of the piezoelectric element.
